PointClickCare Adds Former Appen CEO Armughan Ahmad to Board

Oct 15, 2026
PointClickCare appointed former Appen CEO Armughan Ahmad to its board of directors to support its healthcare AI strategy.

PointClickCare appointed former Appen CEO Armughan Ahmad to its board of directors on October 15, the company announced in a press release. Ahmad will support the health technology company's AI strategy.

Ahmad previously led Appen and served as president and managing partner of digital at KPMG. He also held senior roles at Dell Technologies, where he oversaw hybrid cloud and high performance computing products, including AI systems developed with NVIDIA.

Ahmad also serves on the boards of data center operator Flexential and Ontario hospital system Trillium Health Partners. PointClickCare said Rob Eberle concluded his board service after more than 11 years.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.